ENST00000373294.8:c.1A>G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The ENST00000373294.8(TBX22):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000373294.8 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX22 | NM_001109878.2 | c.1A>G | p.Met1? | start_lost, splice_region_variant | Exon 2 of 9 | ENST00000373296.8 | NP_001103348.1 | |
TBX22 | NM_016954.2 | c.1A>G | p.Met1? | start_lost | Exon 1 of 8 | NP_058650.1 | ||
TBX22 | NM_001109879.2 | c.-356A>G | splice_region_variant | Exon 2 of 9 | NP_001103349.1 | |||
TBX22 | NM_001109879.2 | c.-356A>G | 5_prime_UTR_variant | Exon 2 of 9 | NP_001103349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX22 | ENST00000373294.8 | c.1A>G | p.Met1? | start_lost | Exon 1 of 8 | 1 | ENSP00000362390.5 | |||
TBX22 | ENST00000373296.8 | c.1A>G | p.Met1? | start_lost, splice_region_variant | Exon 2 of 9 | 5 | NM_001109878.2 | ENSP00000362393.3 | ||
TBX22 | ENST00000476373.1 | n.122A>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 2 of 2 | 3 | |||||
TBX22 | ENST00000626498.2 | n.1A>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 2 of 9 | 2 | ENSP00000487527.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
TBX22-related disorder Uncertain:1
The TBX22 c.1A>G variant is predicted to disrupt the translation initiation site (Start loss). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.